At the American Chemical Society Fall National Meeting & Expo, Women Chemists Committee Past WCC Award Winners in Organic & Medicinal Chemistry session, Atomwise member Stephanie Hare, PhD is an invited speaker. Learn what our Atoms have been working on below and visit Atomwise at ACS Fall 2022 National Meeting for other presentation sessions.
Stephane Hare, PhD
Atomwise
Title: Transitioning from academia to industry: How the Merck research award guided me to my dream job
Division: Women Chemists Committee
Abstract
Receiving the Merck Research Award from the Women Chemists’ Committee in 2017 was instrumental in exposing me to careers in the pharmaceutical industry and helped lead me to my current position at a biotech startup. Throughout the process of getting a PhD and doing two separate postdoctoral research positions, I thought I was setting myself up to become a professor at a research university. Like many others, the COVID-19 pandemic made me reconsider where my true priorities lie and catalyzed my transition into an industrial career using computational chemistry for drug discovery. In this talk, I will discuss what my research has looked like over the years, what changed for me in terms of professional goals, and how the connections I made as a result of winning the Merck Research Award played into finding what I call my “dream job”, being a Computer-Aided Drug Design (CADD) scientist at Atomwise Inc. Though no longer an academic myself, a large component of my job at Atomwise is collaborating on projects with academics which allows me the ideal amount of exposure to academic research from the private sector.
DAY & TIME OF PRESENTATION: Wednesday, August 24, 2022 from 8:55 AM - 9:25 AM ROOM & LOCATION: Regency E - Hyatt Regency McCormick Place
Download the presentation deck
Join our team
Our team is comprised of over 80 PhD scientists who contribute to a high-performance academic-like culture that fosters robust scientific and technical excellence. We strongly believe that data wins over opinions, and aim for as little dogma as possible in our decision making. Learn more about our team and opportunities at Atomwise.
